-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Downgrades Heron Therapeutics to Hold

Benzinga·06/03/2026 10:16:21
Listen to the news
Needham analyst Serge Belanger downgrades Heron Therapeutics (NASDAQ:HRTX) from Buy to Hold.